Posts tagged TPP
Here are the top 5 reasons why Doctors Without Borders and more than 50 other organizations don’t like the TPP.
#BadDealForMedicine
The worst trade deal ever for access to medicines is being signed today, but there’s still time to stop it! bit.ly/1StjIBC
The TPP will lock-in high, unsustainable drug prices, delay the availability of price-lowering generic medicines, and price much-needed medical care out of the reach of millions of people. The high price of medicines is a growing problem, especially for developing countries where MSF has medical operations.
#Wishlist2016 Push back on most damaging deal ever for access to meds = #TPP http://www.msfaccess.org/tpp
Looking forward to a bright year ahead, we release our access to medicines Wishlist for 2016 www.msfaccess.org/wishlist2016
President Obama is expected to push for finalization of the Trans-Pacific Partnership (TPP) in tonight’s State of the Union address. MSF is deeply concerned that unless damaging provisions are removed before negotiations are finalized, the TPP agreement could become the most harmful trade pact ever for access to medicines in developing countries. Read why and help us fight back: http://bit.ly/ZLBmEl
MSF OPEN LETTER TO TPP COUNTRIES
As negotiations for the Trans-Pacific Partnership Agreement continue in Malaysia, MSF urges negotiating countries to reject provisions that threaten to restrict access to affordable medicines. Read our open letter to the #TPP countries: http://ow.ly/n16Tb
As negotiations for the Trans-Pacific Partnership (TPP) Agreement move to Malaysia this week, Doctors Without Borders/Médecins Sans Frontières (MSF) urges negotiating countries to remove terms that could block people from accessing affordable medicines, choke off production of generic medicines, and constrain the ability of governments to pass laws in the interest of public health. Read more - http://bit.ly/15yjz3j
Countries Must Fix Critical Access to Medicines Flaws in Trans-Pacific Trade Pact
Negotiations on the Trans-Pacific Partnership (TPP)—a far-reaching trade agreement between 11 Pacific Rim countries—continue to be shrouded in secrecy, but leaked copies of the agreement reveal that the United States is demanding the most harmful package of intellectual property protections ever proposed for a trade agreement with developing countries.
These rules would make it extremely difficult for generic competitors to enter the market, keeping prices unaffordably high, with devastating public health consequences.
The Trans-Pacific Partnership (TPP): A Threat to Affordable Medicines for Millions
The TPP trade deal is currently being negotiated between the US and ten other Pacific Rim nations: Australia, Brunei Darussalam, Canada, Chile, Malaysia, Mexico, New Zealand, Peru, Singapore and Vietnam. The agreement is slated to further expand its membership, potentially to all 21 Asia Pacific APEC nations. The negotiations, which began in 2010, are being conducted in secret, without the opportunity for public scrutiny. However, leaked drafts of the United States government’s proposals for some sections of the agreement reveal the inclusion of dangerous provisions that would dismantle public health safeguards enshrined in international law and restrict access to affordable generic medicines for millions of people in developing countries. To learn more visit, msfaccess.org/TPP
Countries Must Fix Critical Access to Medicines Flaws in Trans-Pacific Trade Pact
Negotiations on the Trans-Pacific Partnership (TPP)—a far-reaching trade agreement between 11 Pacific Rim countries—continue to be shrouded in secrecy, but leaked copies of the agreement reveal that the United States is demanding the most harmful package of intellectual property protections ever proposed for a trade agreement with developing countries.
These rules would make it extremely difficult for generic competitors to enter the market, keeping prices unaffordably high, with devastating public health consequences.
Follow us throughout the week as negotiations for the TPP restart in Lima, Peru, tomorrow.
TAKE ACTION: Tell Members of Congress to Protect Access to Lifesaving Medicins
This is an agreement that wouldn’t just affect the economy and sustainability in these 11 countries, but has the potential to impact the economy and environment for literally half the world. We find it troubling that … U.S. negotiators still refuse to inform the American public what they have been proposing.
In an open letter to the U.S. Congress, 400 organizations demand greater transparency on the Trans-Pacific Partnership (TPP). TPP consists of 11 countries that are pushing to enhance patent and data protections for pharmaceutical companies. Doing so would obstruct price-lowering generic competition for medicines, and turn back years of fighting for universal access to medicines.
Learn more about the TPP and what it means for the international community.
Photo: A Cambodian HIV patient holds some of her drug regimen in an MSF HIV ward. Cambodia 2007 © Dieter Telemans
As closed-door talks for the Trans-Pacific Partnership (TPP) Agreement resume in Singapore this week, MSF calls on the U.S. government to end its stall tactics and revise its proposals for what otherwise promises to be the most harmful trade deal ever for access to medicines in developing countries.
The TPP negotiations, which currently involve eleven Asia-Pacific countries, are being conducted in secret, but leaked texts reveal the most aggressive intellectual property (IP) measures ever suggested in a trade deal with developing countries. The U.S. proposals threaten to roll back internationally-agreed public health safeguards and would put in place far-reaching monopoly protections that keep medicine prices high and out of the reach of millions in the Asia-Pacific region.
“Too many people already die needlessly because the medicines they need are too expensive or do not exist, and we cannot stand by as the Trans-Pacific Partnership threatens to further restrict access to medicines in developing countries,” said Dr. Unni Karunakara, International President of MSF. “We are gravely concerned about countries like Thailand, where MSF started treating HIV/AIDS more than a decade ago and then transitioned its programs to local authorities with the confidence that they would be able to continue providing lifesaving treatments. Now Thailand is on the cusp of joining a dangerous deal that could jeopardize its ability to maintain, let alone scale up, vital, life-saving health programs for its people.”